Literature DB >> 33155201

LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.

W-J Bu1, Z Fang, W-L Li, X Wang, M-J Dong, Q-Y Tao, L Zhang, Y-Q Xu.   

Abstract

OBJECTIVE: LINC00240, as a novel long non-coding RNAs (lncRNAs), has never been studied in hepatocellular carcinoma (HCC). This research reported the expression and function of LINC00240 in HCC. PATIENTS AND METHODS: LINC00240 expression in 180 HCC patients was downloaded from the Cancer Genome Atlas (TCGA) database. HCC patients' survival was analyzed via Kaplan‑Meier analysis. The expression of LINC00240, miR-4465 and HGF in Hep3B and Huh7 cells were regulated by transfection. Cell viability was determined by MTT assay. Transwell experiment was used for the detection of cells migration and invasion abilities. The interaction between LINC00240, miR-4465 and HGF was reflected by Luciferase reporter assay. LINC00240, miR-4465, HGF and p-c-MET expression in HCC cells were researched by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot.
RESULTS: TCGA data showed that high LINC00240 expression was markedly associated with lower survival of HCC patients (p = 0.036). LINC00240 expression was aberrantly upregulated in HCC cells. Silencing of LINC00240 significantly reduced HCC cells viability, migration and invasion. miR-4465 was a target gene of LINC00240. Silencing of LINC00240 reduced HCC cells viability, migration and invasion via directly promoting miR-4465 expression. HGF was target gene of miR-4465. miR-4465 up-regulation obviously suppressed HGF and p-c-MET expression. According to rescue experiment, LINC00240 silencing inhibited HCC cells viability, migration and invasion by suppressing HGF/c-MET signaling pathway via targeting miR-4465.
CONCLUSIONS: LINC00240 sponges miR-4465 to promote HCC cells proliferation, migration and invasion via HGF/c-MET signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33155201     DOI: 10.26355/eurrev_202010_23397

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  CircATIC Contributes to Multiple Myeloma Progression via miR-324-5p-Dependent Regulation of HGF.

Authors:  Bin Wu; Fang Wang; Yuehua Wang; Xianchao Deng; Wangwei Wu
Journal:  Biochem Genet       Date:  2022-05-17       Impact factor: 1.890

2.  Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis.

Authors:  Guoping Wang; Zhongchen Zhang; Chenmei Xia
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 3.  HGF/c-Met: A Key Promoter in Liver Regeneration.

Authors:  Yang Zhao; Wenling Ye; Yan-Dong Wang; Wei-Dong Chen
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

4.  LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.

Authors:  Xing Chen; Guixiang Wu; Jing Qing; Chunlin Li; Xudong Chen; Jian Shen
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

5.  Identify Functional lncRNAs in Nonalcoholic Fatty Liver Disease by Constructing a ceRNA Network.

Authors:  Wei Xue; Jia Zhang; Yali Zhu; Wenxiang Huang
Journal:  ACS Omega       Date:  2022-06-22

6.  Knockdown of Long Noncoding RNA LINC00240 Inhibits Esophageal Cancer Progression by Regulating miR-26a-5p.

Authors:  Yupeng Liu; Tao Li; Chunlei Peng; Qinghua Mao; Biao Shen; Minxin Shi; Haimin Lu; Ting Xiao; Aimin Yang; Chun Cheng
Journal:  Contrast Media Mol Imaging       Date:  2022-10-05       Impact factor: 3.009

7.  LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.

Authors:  Yue Li; Chen Chen; Hai-Lin Liu; Zhen-Fa Zhang; Chang-Li Wang
Journal:  Cell Mol Biol Lett       Date:  2022-10-11       Impact factor: 8.702

8.  Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo.

Authors:  Xiaoyun Ma; Meile Mo; Chao Tan; Jennifer Hui Juan Tan; Huishen Huang; Bihu Liu; Dongping Huang; Shun Liu; Xiaoyun Zeng; Xiaoqiang Qiu
Journal:  J Transl Med       Date:  2022-01-31       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.